PPT-HIV Prevention England Conference

18 February 2020 A twostage randomised phase II placebo controlled clinical trial HIV pipeline for PrEP Simon Collins wwwiBaseinfo UKCAB January 2020 Disclosure A twostage randomised phase II placebo controlled clinical trial. Myron S. Cohen, MD. J. Herbert Bate Distinguished Professor of. Medicine, Microbiology, Immunology, and Public Health. Director, Institute for Global Health and Infectious Diseases. Associate Vice Chancellor for Global Health. A Winnable Battle. Centers for Disease Control and Prevention. Burden of HIV in the United States. . . 1.2 M . ~. 50K. 1.2 million people . living with HIV. Approximately . 50,000 new infections annually. SERVICES FOR LATINA WOMEN:. A GRANT PROPOSAL PROJECT. Lizett. . Morales. California . State University, Long . Beach. May . 2013. Introduction. In the United States, . 1.1 million people are living with HIV . 22. nd. International AIDS Conference, Amsterdam, Netherlands, 23-27 July, 2018 . Pattanasin S. 1. ,. . Cadwell. B. 3. , Smith DK. 3. , . Sukwicha W. 1. , Mock PA. 1. , Wimonsate W. 1. , Ungsedhapand C. State Health Department HIV Programs: . An In-Depth Look. February 23, 3:00pm-4:30pm ET. Logistics for the Webinar. If you are unable to listen to the webinar through your computer speakers, please use your phone:. T. oolbox?. Objectives for Module 1. Our . Mission(s) . Today:. Discuss the difference between HIV prevention for HIV-negative people, HIV prevention for people living with HIV, and HIV testing. Discuss . Presenter:. INTRODUCTION. This project was supported through Federal funds from the Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services Grant # UM01 AI068614: “Leadership Group for a Global HIV Vaccine Clinical Trials (Office of HIV/AIDS Network . Jeffrey B. Joy, Richard H. Liang, Rosemary M. McCloskey, Thuy Nguyen, Chanson J. Brumme, Guillaume Colley, Robert S. Hogg, Julio S.G. Montaner, P. Richard Harrigan, and Art F.Y. Poon. Conflict of Interest. FOR THOSE AT RISK . Robinah. . Nakabugo. , ICW EA. The future with . PrEP. in combination HIV prevention . WHO . &. UNAIDS, Geneva, Switzerland. Wednesday 25. th. March 2015. Background to the presentation. A prevention cascade analysis. Elizabeth Fearon, . Andrew Phillips, . Sibongile. . Mtetwa. , Sungai T . Chabata. , Phillis . Mushati. , Valentina . Cambiano. , Joanna . Busza. , Sue . Napierala. HIV1 and slower to progress to AIDS.. Most cases are due to type1.. Modes of transmission. 1-sexual.. 2- perinatal.. 3-parenteral(occupational and intravenous drug injection).. 4- blood transfusion.. 2018. Objectives . To describe the current situation regarding new HIV infections globally. To list the global HIV prevention targets. To list all types of HIV prevention strategies and know their relative effectiveness. Geneva 2019. Dr Venkatraman Chandra-Mouli. DEFINITIONS . Human immunodeficiency virus (HIV): . A virus that targets the immune system & weakens the body’s defense system against infections. . Antiretroviral medicines (ARVs): . Supporting people who are living with HIV. Preventing others from getting HIV. Achieving. Together. A Community Plan to End the HIV Epidemic in Texas. Prevent HIV Transmission and Acquisition. Increase Viral Suppression.